Outlook Therapeutics Inc
General ticker "OTLK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $48.9M
Outlook Therapeutics Inc does not follow the US Stock Market performance with the rate: -29.4%.
Estimated limits based on current volatility of 1.2%: low 1.33$, high 1.45$
Factors to consider:
- Earnings expected soon, date: 2024-12-27 bmo
- Current price 44.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [3.00$, 11.00$]
- 2024-09-29 to 2025-09-29 estimated range: [2.57$, 8.19$]
Financial Metrics affecting the OTLK estimates:
- Negative: Non-GAAP EPS, $ of -4.80 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -33.97 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.85
- Negative: Industry earnings per price (median), % of -26.09 <= 1.31
Short-term OTLK quotes
Long-term OTLK plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $51.73MM | $63.07MM | $53.13MM |
| Operating Income | $-51.73MM | $-63.07MM | $-53.13MM |
| Non-Operating Income | $-1.43MM | $-2.98MM | $-5.85MM |
| Interest Expense | $0.94MM | $1.49MM | $1.56MM |
| R&D Expense | $38.96MM | $42.33MM | $26.45MM |
| Income(Loss) | $-53.16MM | $-66.05MM | $-58.98MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-53.16MM | $-66.05MM | $-58.98MM |
| Stockholders Equity | $4.61MM | $8.74MM | $-14.44MM |
| Assets | $22.81MM | $28.53MM | $32.30MM |
| Operating Cash Flow | $-54.25MM | $-56.67MM | $-42.97MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $56.19MM | $59.59MM | $48.97MM |
| Earnings Per Share* | $-6.96 | $-6.23 | $-4.72 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.